Rare diseases
Investigational molecules
Locations
Study of Cobolimab and Dostarlimab for Children and Young Adults with Newly Diagnosed or Relapsed/Refractory Tumors
ItalyStudy of Retifanlimab, INCAGN02385, and INCAGN02390 for First-Line Treatment in Patients with PD-L1 Positive Recurrent/Metastatic Head and Neck Cancer
ItalyStudy on the Safety and Effectiveness of Upadacitinib and Dupilumab for Children Aged 2 to 12 with Moderate to Severe Atopic Dermatitis
ItalyStudy of Tucidinostat and Nivolumab for Patients with Advanced Melanoma Not Treated with PD-1 or PD-L1 Inhibitors
ItalyStudy on Atezolizumab, Bevacizumab, and Chemotherapy for Patients with Advanced Cervical Cancer
ItalyStudy Comparing ONC-392 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After PD-1/PD-L1 Inhibitor Treatment
ItalyStudy on the Safety and Effects of EryDex with Dexamethasone Sodium Phosphate for Patients with Ataxia Telangiectasia
ItalyStudy on Long-term Safety and Effects of Efgartigimod PH20 SC for Adults with Bullous Pemphigoid
ItalyStudy on the Safety and Effectiveness of Volrustomig with a Drug Combination for Patients with Solid Tumors
ItalyStudy on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ItalyStudy of Selinexor for Patients with Previously Treated Myelofibrosis
ItalyStudy of Romidepsin and Drug Combination for Young Patients with Peripheral T-Cell Lymphomas Before Stem Cell Transplantation
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
